Home
/
GE HealthCare Technologies Inc.
/
Financials
/
Quarterly
GE HealthCare Technologies Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that GE HealthCare Technologies Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$5.14B
Oct 29, 2025
Q2
2025
Jun 30, 2025
$5.01B
Jul 30, 2025
Q1
2025
Mar 31, 2025
$4.78B
Apr 30, 2025
Q3
2025
Sep 30, 2024
$4.86B
Oct 29, 2025
Q2
2025
Jun 30, 2024
$4.84B
Jul 30, 2025
Q1
2025
Mar 31, 2024
$4.65B
Apr 30, 2025
Q3
2024
Sep 30, 2023
$4.82B
Oct 30, 2024
Q2
2024
Jun 30, 2023
$4.82B
Jul 31, 2024
Q1
2024
Mar 31, 2023
$4.71B
Apr 30, 2024
Q3
2023
Sep 30, 2022
$4.58B
Oct 31, 2023
Q2
2023
Jun 30, 2022
$4.48B
Jul 25, 2023
Q1
2023
Mar 31, 2022
$4.34B
Apr 25, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$446.00M
Oct 29, 2025
Q2
2025
Jun 30, 2025
$486.00M
Jul 30, 2025
Q1
2025
Mar 31, 2025
$564.00M
Apr 30, 2025
Q3
2025
Sep 30, 2024
$470.00M
Oct 29, 2025
Q2
2025
Jun 30, 2024
$428.00M
Jul 30, 2025
Q1
2025
Mar 31, 2024
$374.00M
Apr 30, 2025
Q3
2024
Sep 30, 2023
$375.00M
Oct 30, 2024
Q2
2024
Jun 30, 2023
$418.00M
Jul 31, 2024
Q1
2024
Mar 31, 2023
$372.00M
Apr 30, 2024
Q3
2023
Sep 30, 2022
$487.00M
Oct 31, 2023
Q2
2023
Jun 30, 2022
$485.00M
Jul 25, 2023
Q1
2023
Mar 31, 2022
$389.00M
Apr 25, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$653.00M
Oct 29, 2025
Q2
2025
Jun 30, 2025
$654.00M
Jul 30, 2025
Q1
2025
Mar 31, 2025
$629.00M
Apr 30, 2025
Q3
2025
Sep 30, 2024
$676.00M
Oct 29, 2025
Q2
2025
Jun 30, 2024
$608.00M
Jul 30, 2025
Q1
2025
Mar 31, 2024
$540.00M
Apr 30, 2025
Q3
2024
Sep 30, 2023
$617.00M
Oct 30, 2024
Q2
2024
Jun 30, 2023
$570.00M
Jul 31, 2024
Q1
2024
Mar 31, 2023
$559.00M
Apr 30, 2024
Q3
2023
Sep 30, 2022
$605.00M
Oct 31, 2023
Q2
2023
Jun 30, 2022
$631.00M
Jul 25, 2023
Q1
2023
Mar 31, 2022
$509.00M
Apr 25, 2023